FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Wizcure Pharmaa Private CHNaO Fluorescein Sodium Ophthalmic Strips Recall

CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count box

Wizcure Pharmaa Private Limited · Bhiwadi, N/A

Risk level
Class II
Reported by FDA
Mar 4, 2026
Recall ID
D-0350-2026
Check your lot numberHow we source this data

Summary

Wizcure Pharmaa Private recalled CHNaO Fluorescein Sodium Ophthalmic Strips starting Dec 31, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0350-2026 on Mar 4, 2026. Reason: Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Product description

CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count box, NDC 83851-100-10; b) 300-count box, NDC 83851-100-30. Manufactured by Wizcure Pharmaa PVT. LTD, H-681, Phase 3, RIICO Industrial Area, Bhiwadi- 301019 INDIA, Vistamerica USA, 20 Perkins Dr. Prescott, AZ 86301, Vistamerica USA, Made in India,

Lot numbers, UPCs & expiration codes

All lots

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0350-2026
Classification
Class II
Status
Ongoing
Recall initiated
Dec 31, 2025
FDA report date
Mar 4, 2026
Quantity
10,080 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Wizcure Pharmaa Private Limited

Original FDA data

Every field from FDA enforcement report D-0350-2026, exactly as published.

Show all FDA fields
City
Bhiwadi
Status
Ongoing
Country
India
Event ID
98253
Address
H - 881
Code information
All lots
Report date
Mar 4, 2026
Product type
Drugs
Recall number
D-0350-2026
Classification
Class II
Recalling firm
Wizcure Pharmaa Private Limited
Product quantity
10,080 boxes
Reason for recall
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Voluntary / mandated
Voluntary: Firm initiated
Product description
CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count box, NDC 83851-100-10; b) 300-count box, NDC 83851-100-30. Manufactured by Wizcure Pharmaa PVT. LTD, H-681, Phase 3, RIICO Industrial Area, Bhiwadi- 301019 INDIA, Vistamerica USA, 20 Perkins Dr. Prescott, AZ 86301, Vistamerica USA, Made in India,
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Dec 31, 2025
Initial firm notification
Letter
Center classification date
Feb 25, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0350-2026, published Mar 4, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls